LIPOPROTEIN(A) AND PREVALENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Barkas, F. [1 ]
Koutsogianni, A. [1 ]
Adamidis, P. [1 ]
Anastasiou, G. [1 ]
Sakkou, S. -F. [1 ]
Kyrili, K. [1 ]
Liamis, G. [1 ]
Liberopoulos, E. [2 ]
机构：
[1] Univ Ioannina, Sch Hlth Sci, Dept Internal Med, Fac Med, Ioannnina, Greece
[2] Natl & Kapodistrian Univ Athens, Propaideut Dept Med 1, Sch Med, Athens, Greece
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP160
引用
收藏
页码：E136 / E137
页数：2
相关论文
共 50 条
  • [1] Lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease
    Williams, Kathryn L.
    Augustine, Maya
    Sujakhu, Eru
    Magadia, Justine
    Crawford, Lindsay
    Knott, Aimee
    Hamilton, Skyler
    Obiaka, Uzoma
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2025, 76
  • [2] Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease
    Rana, Jamal S.
    Liu, Jennifer Y.
    Moffet, Howard H.
    Sanchez, Robert J.
    Khan, Irfan
    Karter, Andrew J.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (02): : 200 - 206
  • [3] Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah
    Mansour, Abbas Ali
    Ajeel, Narjis A. H.
    WORLD JOURNAL OF DIABETES, 2013, 4 (03) : 82 - 87
  • [4] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [5] Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
    Cai Xiaoling
    Lin Chu
    Ji Linong
    中华医学杂志英文版, 2022, 135 (21)
  • [6] Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
    Cai, Xiaoling
    Lin, Chu
    Ji, Linong
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2605 - 2607
  • [7] Atherosclerotic Cardiovascular Disease in Diabetes Patients
    Amelia, Rina
    Wahyuni, Arlinda Sari
    Yunanda, Yuki
    Wijaya, Hendri
    CURRENT DIABETES REVIEWS, 2023, 19 (08) : 62 - 69
  • [8] Optimization of Medication Regimens in Patients with Type 2 Diabetes and Clinical Atherosclerotic Cardiovascular Disease
    Prudencio, Jarred
    Cajudoy, Paige
    Waddell, Donald
    PHARMACY, 2021, 9 (04)
  • [9] Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes
    Standl, Eberhard
    Schnell, Oliver
    McGuire, Darren K.
    Ceriello, Antonio
    Ryden, Lars
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 391 - 402
  • [10] Screening for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: Controversies and Guidelines
    Raggi, Paolo
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 86 - 92
12345